Trial intelligence / Profile preview

Reduction of traumatic memory reconsolidation with propranolol: pilot study

2006-007068-27Phase 2Active

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Change in PTSD symptom intensity. Started Feb 2007; status: active.

02

Drugs

propranolol
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on 2006-007068-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-007068-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call